Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina L Tutykhina

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|November 25, 2010
Development of adenoviral vector-based mucosal vaccine against influenzaIrina L Tutykhina, Denis Y Logunov, Dmitriy N Shcherbinin, et al.
Protein Expression and Purification|January 29, 2009
Production of recombinant human lactoferrin in the allantoic fluid of embryonated chicken eggs and its characteristicsIrina L Tutykhina, Olga A Bezborodova, Maxim M Shmarov, et al.
Microbial Pathogenesis|August 16, 2022
Biofilm matrix proteome of clinical strain of P. aeruginosa isolated from bronchoalveolar lavage of patient in intensive care unitDaria A Egorova, Andrey I Solovyev, Nikita B Polyakov, et al.
Antiviral Research|January 1, 2013
Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infectionIrina L Tutykhina, Elena S Sedova, Irina Y Gribova, et al.
Journal of Virology|June 29, 2007
Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifsDenis Y Logunov, Olga V Zubkova, Anna S Karyagina-Zhulina, et al.
Antiviral Research|January 1, 2013
Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)Sergei V Tillib, Tatiana I Ivanova, Lev A Vasilev, et al.
Frontiers in Immunology|May 11, 2026
Circular mRNA against CleanCap linear mRNA vectors: comprehensive comparison, expression, active and passive immunizationVladimir M Vakhtinskii, Irina L Tutykhina, Alina S Dzharullaeva, et al.
Frontiers in Immunology|April 10, 2025
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and RussiaDenis Y Logunov, Inna V Dolzhikova, Mamadou Y Boiro, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Molecular Medicine (Berlin, Germany)|November 25, 2010
Development of adenoviral vector-based mucosal vaccine against influenzaIrina L Tutykhina, Denis Y Logunov, Dmitriy N Shcherbinin, et al.
Protein Expression and Purification|January 29, 2009
Production of recombinant human lactoferrin in the allantoic fluid of embryonated chicken eggs and its characteristicsIrina L Tutykhina, Olga A Bezborodova, Maxim M Shmarov, et al.
Microbial Pathogenesis|August 16, 2022
Biofilm matrix proteome of clinical strain of P. aeruginosa isolated from bronchoalveolar lavage of patient in intensive care unitDaria A Egorova, Andrey I Solovyev, Nikita B Polyakov, et al.
Antiviral Research|January 1, 2013
Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infectionIrina L Tutykhina, Elena S Sedova, Irina Y Gribova, et al.
Journal of Virology|June 29, 2007
Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifsDenis Y Logunov, Olga V Zubkova, Anna S Karyagina-Zhulina, et al.
Antiviral Research|January 1, 2013
Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)Sergei V Tillib, Tatiana I Ivanova, Lev A Vasilev, et al.
Frontiers in Immunology|May 11, 2026
Circular mRNA against CleanCap linear mRNA vectors: comprehensive comparison, expression, active and passive immunizationVladimir M Vakhtinskii, Irina L Tutykhina, Alina S Dzharullaeva, et al.
Frontiers in Immunology|April 10, 2025
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and RussiaDenis Y Logunov, Inna V Dolzhikova, Mamadou Y Boiro, et al.
Pageof 1